Synfacts, Inhaltsverzeichnis

Synfacts 2023; 19(11): 1151
DOI: 10.1055/s-0042-1751596

Innovative Drug Discovery and Development

Discovery of SMD-3040 as a Potent and Selective Degrader for the Synthetic Lethality Target, SMARCA2

Rezensent(en):

Antonia F. Stepan (Roche)

,

Seong Heon Kim (Hyundai Pharm)